BioTelemetry Inc. (BEAT) stock coverage started with “Buy” in note to investors by Dougherty & Co

BioTelemetry Inc. (NASDAQ: BEAT) shares rose on Friday Dec 2 with lighter trade volume than normal after more analysts initiated coverage on the stock.

Meanwhile, U.S. stocks edged lower on Friday, with major indexes on track for a weekly decline.

The Dow Jones Industrial Average DJIA, -0.14% fell 23 points, or 0.1%, to 19,169, while the S&P 500 SPX, +0.09% lost 1.2 point to 2,190, a move of less than 0.1%. The Nasdaq Composite COMP, -0.15% fell 5.3 points, or 0.1%, to 5,247.

Analysts at Dougherty & Co initiated coverage on BioTelemetry Inc. (NASDAQ: BEAT) stock, rating the company at Buy. With a rating of Buy on the stock, BioTelemetry Inc. has a 52-week high of $21.68. The one-year price target of $25.33 is higher than the opening price of $20.10, causing a fair amount of other analysts to issue statements on the stock in recent days. Analysts and brokerage firms will subsequently issue periodic updates after beginning or initiating coverage. Changes in price targets are not unusual.

BioTelemetry Inc. (NASDAQ: BEAT) shares last traded at $20.30, which represents a jump of $0.50 or 2.53% from the previous closing price. Opening at $20.10, they varied from $19.67 and $20.35 throughout the day.

BioTelemetry Inc. (NASDAQ: BEAT) now has a market cap of 573.09M.

BioTelemetry Inc. (NASDAQ: BEAT) Average Daily Trading Volume

The stock’s average daily volume is 308,586 shares out of a total float 27,666,000 and some 26,757 shares crossed the trading desk yesterday, lower than normal. Momentum traders often use swings in trading volume to identify heavy volume aggregation or distribution by institutional investors, so look for trading volume to pick up in the coming days.

While higher trading for one day will not mean much, however, a trend of heavy trading volume on the buy side over a series of days or weeks sends a positive cue to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors retain substantial teams of analysts researching thousands of stocks, so it is good corroboration to see them buying a stock you are researching.

BioTelemetry Inc. (NASDAQ: BEAT) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By marking the activity of these professional investors—and the moving averages they affect—it allows for traders to make more impactful decisions on trades.

Trades for BioTelemetry Inc. (NASDAQ: BEAT) have ranged from $8.74 – 21.68, and the stock now has a 50-day MA of $18.31 and 200-day MA of $18.08. Today’s last price is 6.37%% under the 52 week high of $21.68.

Earnings growth is a crucial factor to look at when investing in stocks and investors identify companies that have grown their earnings by at least 25% over the past 3 years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *